New patent for Fresenius Kabi drug LEVOTHYROXINE SODIUM

   November 15, 2021    Comments Off on New patent for Fresenius Kabi drug LEVOTHYROXINE SODIUM    Posted in: Patent Added

Annual Drug Patent Expirations for LEVOTHYROXINE+SODIUM Levothyroxine Sodium is a drug marketed by Teva Pharms Usa Inc, Dr Reddys, Fresenius Kabi Usa, Maia Pharms Inc, Par Sterile Products, Piramal Critical,…

The post New patent for Fresenius Kabi drug LEVOTHYROXINE SODIUM appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog